| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Ubiquitin carboxyl-terminal hydrolase 30 |
|---|
| Ligand | BDBM445170 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | USP30 Biochemical IC50 Assay |
|---|
| IC50 | <100±n/a nM |
|---|
| Citation |  Kemp, M; Stockley, M; Jones, A Cyanopyrrolidines as dub inhibitors for the treatment of cancer US Patent US10669234 Publication Date 6/2/2020 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Ubiquitin carboxyl-terminal hydrolase 30 |
|---|
| Name: | Ubiquitin carboxyl-terminal hydrolase 30 |
|---|
| Synonyms: | Deubiquitinating enzyme 30 | UBP30_HUMAN | USP30 | Ub-specific protease 30 | Ubiquitin carboxyl-terminal hydrolase 30 (USP30) | Ubiquitin thioesterase 30 | Ubiquitin-specific-processing protease 30 |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 58522.90 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q70CQ3 |
|---|
| Residue: | 517 |
|---|
| Sequence: | MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERK
KRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTL
LHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQ
PRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQ
SPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEK
VEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLG
HKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMP
FPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDT
VRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE
|
|
|
|---|
| BDBM445170 |
|---|
| n/a |
|---|
| Name | BDBM445170 |
|---|
| Synonyms: | (S)-1-Cyano-N-(4-(6-cyanopyridin-2-yl)thiazol-2-yl)-N-methylpyrrolidine-2-carboxamide | US10669234, Example 77 | US11319287, Example 77 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C16H14N6OS |
|---|
| Mol. Mass. | 338.387 |
|---|
| SMILES | CN(C(=O)[C@@H]1CCCN1C#N)c1nc(cs1)-c1cccc(n1)C#N |r| |
|---|
| Structure | 
|
|---|
Search and Browse
